NMR Assays for Carbohydrate-Based Vaccines

NMR Spectroscopy in Pharmaceutical Analysis

Volumn , Issue , 2008, Pages 341-368

  Jones, C ^a   Ravenscroft, N ^b  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78650752473     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-444-53173-5.00014-7     Document Type: Chapter

References (92)

1. Anonymous (2003) Wkly. Epidemiol. Rec. 78 110-119.
2. J. Eskola and M. Anttila (1999) Pediatr. Infect. Dis. 18 543-551.
3. Anonymous (1998) Wkly. Epidemiol. Rec. 73 64-68.
4. Anonymous (2002) Wkly. Epidemiol. Rec. 77 331-339.
5. K.L. Kotloff, J.P. Winickoff, B. Ivanoff, J.D. Clemens, D.L. Swerdlow, P.J. Sansonetti, G.K. Adak and M.M. Levine (1999) Bull. World Health Organ. 77 651-666.
6. J.A. Crump, S.P. Luby and E.D. Mintz (2004) Bull. World Health Organ. 82 346-353.
7. R. Edelman and M.M. Levine (1986) Rev. Infect. Dis. 8 329-349.
8. http://www.who.int/child-adolescent-health/New_Publications/IMCI/WHO_FCH_CAH_01.10/Young_Infant
9. B. Ivanoff and C.L. Chaignat (2002) Bull Soc. Pathol. Exot. 95 355-358.
10. A. Sinha, O. Levine, M.D. Knoll, F. Muhib and T.A. Lieu (2007) Lancet 369 389-396.
11. Wyeth Reports Earnings Results for the 2007 Second Quarter and First Half (July 19, 2007) http://www.wyeth.com/news/announcements (accessed 26 August 2007)
12. http://www.who.int/vaccine_research/about/gvrf/Jadhav.pdf
13. I. Roitt (1997) Essential Immunology. 9th ed. Oxford: Blackwell Scientific
14. I. Goldschneider, E.C. Gotschlich and M.S. Artenstein (1969) J. Exp. Med. 129 1307-1326.
15. A.A. Lindberg (1999) Vaccine 17 S28-S36.
16. C. Jones (2005) An. Acad. Bras. Cienc. 77 293-324.
17. J.F.G. Vliegenthart (2006) FEBS Lett. 580 2945-2950.
18. C. Jones (2007) Comprehensive Glycoscience. J.P. Kamerling (Eds) Oxford, UK: Elsevier
19. K.L. O’Brien, M. Hochman and D. Goldblatt (2007) Lancet Infect. Dis. 7 597-606.
20. H.J. Jennings (1990) Curr. Top. Microbiol. Immunol. 150 97-127.
21. The Jordan Report on the Accelerated Development of Vaccines: see http://www.niaid.nih.gov/dmid/vaccines/jordan20
22. V. Verez-Bencomo, V. Fernández-Santana, E. Hardy, et al. (2004) Science 305 522-525.
23. V.N. Shibaev (1986) Adv. Carbohydr. Chem. Biochem. 44 277-339.
24. M.M. McGowen, J. Vionnet and W.F. Vann (2001) Glycobiology 11 613-620.
25. J.P. Kamerling (2000) Pneumococcal polysaccharides: a chemical view. A. Tomasz (Eds) Streptococcus pneumoniae 81-114. Mary Anne Liebert, Larchmont
26. B. Lindberg (1990) Adv. Carbohydr. Chem. Biochem. 48 279-318.
27. P. Branefors-Helander, C. Erbing, L. Kenne and B. Lindberg (1976) Acta Chem. Scand., B 30 276-277.
28. R.M. Crisel, R.S. Baker and D.E. Dorman (1975) J. Biol. Chem. 250 4926-4930.
29. D.R. Bundle, I.C.P. Smith and H.J. Jennings (1974) J. Biol. Chem. 249 2275-2281.
30. A.K. Bhattacharjee, H.J. Jennings, C.P. Kenny, A. Martin and D.R. Bundle (1975) J. Biol. Chem. 250 1926-1932.
31. A.K. Bhattacharjee, H.J. Jennings, C.P. Kenny, A. Martin and D.R. Bundle (1976) Can. J. Biochem. 54 1-8.
32. K. Heyns and G. Kiessling (1967) Carbohydr. Res. 3 340-353.
33. C.J.M. Stroop, Q. Xu, M. Retzlaff, C. Abeygunawardana and C.A. Bush (2002) Carbohydr. Res. 337 335-344.
34. P.E. Jansson, B. Lindberg, M. Andersson, U. Lindquist and J. Henrichsen (1998) Carbohydr. Res. 182 111-117.
35. R.E. Reeves and W.F. Goebel (1941) J. Biol. Chem. 139 511-519.
36. C. Jones, F. Currie and M.J. Forster (1991) Carbohydr. Res. 221 95-121.
37. P.E. Jansson, B. Lindberg and U. Lindquist (1985) Carbohydr. Res. 140 101-110.
38. L. Kenne, B. Lindberg and J.K. Madden (1979) Carbohydr. Res. 73 175-182.
39. C. Jones, B. Mulloy, A. Wilson, A. Dell and J.E. Oates (1985) J. Chem. Soc. Perkin Trans. 1 1665-1673.
40. B. Lindberg, J. Lonngren and D.A. Powell (1977) Carbohydr. Res. 58 177-186.
41. J. Lindberg (1990) Thesis Stockholm University.
42. E. Katzenellenbogen and H.J. Jennings (1983) Carbohydr. Res. 124 235-245.
43. H.J. Jennings, K.-G. Rosell and D.J. Carlo (1980) Can. J. Chem. 58 1069-1074.
44. J.C. Richards and M.B. Perry (1988) Biochem. Cell Biol. 66 758-771.
45. C. Jones (2005) Carbohydr. Res. 340 1097-1106.
46. M. Tylianakis, A. Spyros, P. Dais, F.R. Taravel and A. Perico (1999) Carbohydr. Res. 315 16-34.
47. European Pharmacopoeia (2008) European Directorate for the Quality of Medicines. 6th Ed. France: Strasbourg 816–818
48. European Pharmacopoeia (2008) European Directorate for the Quality of Medicines. 6th Ed. France: Strasbourg 827–829
49. European Pharmacopoeia (2008) European Directorate for the Quality of Medicines. 6th Ed. France: Strasbourg 847–848
50. European Pharmacopoeia (2008) European Directorate for the Quality of Medicines. 6th Ed. France: Strasbourg 792–794
51. X. Lemercinier and C. Jones (2000) Biologicals 28 75-83.
52. X. Lemercinier and C. Jones (1996) Carbohydr. Res. 296 83-96.
53. C. Abeygunawardana, T.C. Williams, J.S. Sumner and J.P. Hennessey Jr (2000) Anal. Biochem. 279 226-240.
54. X. Lemercinier, I. Martinez-Cabrera and C. Jones (2000) Biologicals 28 17-24.
55. Anonymous (2000) World Health Organ. Tech. Rep. Ser. 897 27. http://whqlibdoc.who.int/trs/WHO_TRS_897.pdf
56. Anonymous (2004) World Health Organ. Tech. Rep. Ser. 924 102-128.
57. Anonymous (2005) World Health Organ. Tech. Rep. Ser. 927 64-98.
58. Anonymous: Available through http://www.who.int/biologicals/publications/trs/areas/vaccines/meningococcal/en/index.html
59. Anonymous (2007) Pharmeuropa 19 323-327.
60. Anonymous (2008) European Pharmacopoeia. 6th Ed. Strasbourg 39–41
61. J.M. Wieruszeski, P. Talaga and G. Lippens (2005) Anal. Biochem. 338 20-25.
62. C. Abeygunawardana (2001) High resolution NMR Applications in polysaccharide-based vaccines. Abstracts of the 222nd ACS Annual meeting Chicago IL, August 26th–30th
63. W. Fischer, T. Behr, R. Hartmann, J. Peter-Katalinic and H. Egge (1993) Eur. J. Biochem. 215 851-857.
64. W. Egan (2000) Dev. Biol. 103 3-9.
65. X.D. Wu, R.A. Kircher, P.H. McVerry and D.A. Malinzak (2000) Dev. Biol. 103 269-270.
66. Q. Wu, C. Abeygunawardana, A.S. Ng, A.W. Sturgess, B.J. Harmon and J.P. Hennessey (2005) Anal. Biochem. 336 262-272. erratum ibid., 342 (2006) 258
67. E.C. Gotschlich, B.A. Fraser, O. Nishimura, J.B. Robbins and T.Y. Liu (1981) J. Biol. Chem. 256 8915-8921.
68. J.S. Kuo, V.W. Doelling, J.F. Graveline and D.W. McCoy (1985) J. Bacteriol. 163 769-773.
69. A. Bardotti, N. Ravenscroft, S. Ricci, S. D’Ascenzi, V. Guarnieri, G. Averani and P. Constantino (2000) Vaccine 18 1982-1993.
70. C.M. Tsai, X.X. Gu and R.A. Byrd (1994) Vaccine 12 700-706.
71. F. Mawas, B. Bolgiano, P. Rigsby, D. Crane, D. Belgrave and M.J. Corbel (2007) Biologicals 35 235-245.
72. A.L. Stone and S.C. Szu (1988) J. Clin. Microbiol. 26 719-725.
73. C. Jones, X. Lemercinier, D.T. Crane, C. Gee, B. Bolgiano and S. Austin (1999) Dev. Biol. Stand. 101 177-183.
74. C. Jones, X. Lemercinier, D.T. Crane, C.K. Gee and S. Austin (2000) Dev. Biol. 103 121-136.
75. N. Ravenscroft, G. Averani, A. Bartoloni, S. Berti, M. Bigio, V. Carinci, P. Costantino, S. D’Ascenzi, A. Giannozzi, F. Norelli, C. Pennatini, D. Proietti, C. Ceccarini and P. Cescutti (1999) Vaccine 17 2802-2816.
76. A. Pawlowski and S.B. Svenson (1999) FEMS Microbiol. Lett. 174 255-263.
77. X. Cai, Q.P. Lei, D.H. Lamb, A. Shannon, J. Jacoby, J. Kruk, R.D. Kensinger, R. Ryall, E. Zablackis and P. Cash (2004) Anal. Chem. 76 7387-7390.
78. Q. Xu, J. Klees, J. Teyral, R. Capen, M. Huang, A.W. Sturgess, J.P. Hennessey Jr, M. Washabaugh, R. Sitrin and C. Abeygunawardana (2005) Anal. Biochem. 337 235-245.
79. J.Y. Tai, P.P. Vella, A.A. McLean, A.F. Woodhour, W.J. McAleer, A. Sha, C. Dennis-Sykes and M.R. Hilleman (1987) Proc. Soc. Exp. Biol. Med. 184 154-161.
80. O. de Weers, M. Beurret, L. van Buren, L.A. Oomen, J.T. Poolman and P. Hoogerhout (1998) Bioconjug. Chem. 9 309-315.
81. A. Lees, B.L. Nelson and J.J. Mond (1996) Vaccine 14 190-198.
82. A.J. D’Ambra, J.E. Baugher, P.E. Concannon, R.A. Pon and F. Michon (1997) Anal. Biochem. 250 228-236.
83. Z. Kossaczka, S. Bystricky, D.A. Bryla, J. Shiloach, J.B. Robbins and S.C. Szu (1997) Infect. Immun. 65 2088-2093.
84. S.C. Szu, A.L. Stone, J.D. Robbins, R. Schneerson and J.B. Robbins (1986) J. Exp. Med. 166 1510-1524.
85. C.A. Laferrière, R.K. Sood, J.M. de Muys, F. Michon and H.J. Jennings (1997) Vaccine 15 179-186.
86. N. Ravenscroft (2000) Pharmeuropa Special Issue: Biologicals Beyond 2000: Challenges for Quality Standards in an Evolving Field. Strasbourg, France: European Directorate for the Quality of Medicines
87. A. Bardotti, G. Averani, F. Berti, S. Berti, C. Galli, S. Giannini, B. Fabbri, D. Proietti, N. Ravenscroft and S. Ricci (2005) Vaccine 23 1887-1899.
88. N. Ravenscroft, S. D’Ascenzi, D. Proietti, F. Norelli and P. Costantino (2000) Dev. Biol. 103 35-47.
89. N. Ravenscroft, J. Chen, M. Hearshaw, P. Mensah, M. LaForce, J.-M. Prenaud, S. Viviani, S. Beri, J. Joshi and K. Suresh (2006) 15th International Pathogenic Neisseria Conference, Cairns, Australia,8.3.09
90. J.S. Kim, E.R. Laskowich, F. Michon, R.E. Kaiser and R.G. Arumugham (2006) Anal. Biochem. 358 136-142.
91. G.R. Siber (1994) Science 265 1385-1387.
92. J.S. Kim, E.R. Laskowich, R.G. Arumugham, R.E. Kaiser and G.J. MacMichael (2005) Anal. Biochem. 347 262-274.